Research and Markets: Global Prenatal and Newborn Genetic Testing Market 2015-2019 with Agilent Technologies, Bio-Rad Laboratories, Illumina & Sequenom Dominating

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/h7vwq8/global_prenatal) has announced the addition of the "Global Prenatal and Newborn Genetic Testing Market 2015-2019" report to their offering.

The Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91% over the period 2014-2019

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.

One key trend emerging in this market is the launch of new tests. For instance, in 2014, Laboratory Corporation of America Holdings launched the informaSeq Prenatal Test. In the same year, Sequenom launched the VisibiliT laboratory-developed test in international markets.

According to the report, one of the major drivers of the market is the growing incidence of fetal health-related abnormalities such as Down syndrome, Edward syndrome, neural tube defects, sickle cell anemia, thalassemia, Tay-Sachs disease, spina bifida, cystic fibrosis, cleft palate, muscular dystrophy, and fragile X syndrome.

Further, the report states that a decrease in fertility rates worldwide is one of the main challenges that the market faces. This has led to a decline in the number of pregnancies, resulting in a reduction in the demand for prenatal and newborn testing

The Global Prenatal and Newborn Genetic Testing market can be divided into two segments:

  • Diagnostic Techniques
  • Screening Methods

Key Vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Illumina
  • Sequenom

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Technology
  8. Prenatal Screening Tests
  9. Causes and Risk Factors
  10. Genetic Disorders before Birth
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/h7vwq8/global_prenatal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Imaging

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Imaging